Atopic Dermatitis (Eczema) clinical trials at UCLA
5 in progress, 4 open to eligible people
APG777 in Atopic Dermatitis
open to eligible people ages 18 years and up
This is a two-part study that will evaluate the safety and efficacy of APG777 in participants with moderate-to-severe Atopic Dermatitis (AD). Part A (Proof-of-concept) and Part B (Dose-regimen Finding) will evaluate the safety and efficacy of various induction and maintenance dose regimens of APG777 compared to placebo. The study duration for any individual participant will be up to 106 weeks which includes: screening, induction, maintenance, and post-treatment follow-up periods. Participants randomized in Part A are not permitted to participate in Part B.
Los Angeles 5368361, California 5332921 and other locations
Barzolvolimab in Patients With Atopic Dermatitis
open to eligible people ages 18 years and up
The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with Atopic Dermatitis
Los Angeles 5368361, California 5332921 and other locations
JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD)
open to eligible people ages 18 years and up
The purpose of this study is to evaluate how well JNJ-95475939 works as compared to placebo in participants with moderate to severe atopic dermatitis.
Los Angeles 5368361, California 5332921 and other locations
Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis
open to eligible people ages 18 years and up
The purpose of this study is to assess the efficacy and safety of Afimkibart (also known as RO7790121) in participants with moderate to severe atopic dermatitis (AD).
Los Angeles 5368361, California 5332921 and other locations
Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
Sorry, in progress, not accepting new patients
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Los Angeles 5368361, California 5332921 and other locations
Last updated: